Skip to Content
Home > Clinical Trials Search Results
View Additional Section Content
RATIONALE: Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Interferon alfa-2b may interfere with the growth of tumor cells and slow the growth of melanoma and other cancers. It is not yet known whether ipilimumab is more effective then interferon alfa-2b in treating patients with melanoma. (NCT01274338)
My AH Link
© 2014 Abington Health. All rights reserved.
1200 Old York Road, Abington, PA 19001